Welcome to Managing MDS!
| Managing MDS is a dynamic and evolving website specializing in providing education, resources, and tools for community oncologists who treat patients with myelodysplastic syndromes with the ultimate goal of improving patient outcomes. |
What's New
| CE Education Treatment Advances in Acute Myeloid Leukemia and Myelodysplastic Syndromes Vijaya Raj Bhatt, MD; Mikkael A. Sekeres, MD |
| CE Education Anemia and the Low-risk MDS Patient: The Current Landscape and Future Directions Shyamala C. Navada, MD, MSCR |
| CE Education MDS in the Lower-risk Patient: The Current Treatment Algorithm Hetty E. Carraway, MD, MBA, FACP |
| CE Education Practical Strategies for Improving Outcomes in MDS: New HMAs, Combination and Novel Treatments Aziz Nazha, MD |
| Frequently Asked Questions What are the key investigational studies to keep an eye on in higher-risk MDS patients in the post-AZA setting? Rami S. Komrokji, MD |
| Frequently Asked Questions As a community practitioner, what key factors do I need to remember in determining treatment options for my patients? Rami S. Komrokji, MD View all FAQs |
| Clinical Pearls Podcasts How will ASTX727 be used in clinic? Guillermo Garcia-Manero, MD |